Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Amplify Therapeutics ApS
APS
Active
Advertising protection
CVR 43803999
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 3 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Amplify Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-2M
2023
-5M
2024
1M
2025
EBITDA
DKK millions
0M
-3M
-5M
-8M
-10M
-2M
2023
-8M
-300%
2024
-4M
+50%
2025
Income statement
DKK thousands
Item
2023
2024
2025
Gross profit
-1.559
-4.962
926
Staff expenses
-825
-3.319
-4.786
EBITDA
-2.384
-8.280
-3.860
Depreciation & amort.
-0
-0
-0
EBIT
-2.384
-8.280
-3.860
Net financials
-95
-497
-845
Profit before tax
-2.479
-8.777
-4.705
Tax
-526
-1.583
-1.369
Net profit
-1.953
-7.195
-3.336
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
2.630
5.945
3.363
Equity
-1.913
-9.108
-12.443
Long-term debt
4.098
14.597
15.448
Short-term debt
445
455
358
Total debt
4.542
15.052
15.806
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-416.8%
This company
2023
2025
Equity ratio
-370.0%
This company
38.2%
Market median
-1069% vs market
2023
2025
Return on equity
-333584400.0%
This company
18.4%
Market median
-1812958796% vs market
2023
2025
Net profit margin (of gross profit)
-360.3%
This company
2023
2025
Asset turnover (of gross profit)
0.28×
This company
2023
2025
Debt / equity
1.27×
This company
0.62×
Market median
-105% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-23 – 2023-12-31
View
PDF
More on Amplify Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
